Delta Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,825
| Closed | -$215K | – | 205 |
|
|
2023
Q1 | $215K | Hold |
2,825
| – | – | 0.06% | 173 |
|
|
2022
Q4 | $234K | Hold |
2,825
| – | – | 0.08% | 157 |
|
|
2022
Q3 | $224K | Hold |
2,825
| – | – | 0.1% | 150 |
|
|
2022
Q2 | $210K | Sell |
2,825
-232
| -8% | -$17.2K | 0.1% | 124 |
|
|
2022
Q1 | $275K | Hold |
3,057
| – | – | 0.08% | 120 |
|
|
2021
Q4 | $342K | Hold |
3,057
| – | – | 0.1% | 133 |
|
|
2021
Q3 | $384K | Hold |
3,057
| – | – | 0.12% | 115 |
|
|
2021
Q2 | $414K | Hold |
3,057
| – | – | 0.12% | 115 |
|
|
2021
Q1 | $415K | Buy |
3,057
+1
| +0% | +$136 | 0.13% | 109 |
|
|
2020
Q4 | $430K | Buy |
3,056
+4
| +0.1% | +$563 | 0.14% | 112 |
|
|
2020
Q3 | $340K | Buy |
3,052
+2
| +0.1% | +$223 | 0.18% | 87 |
|
|
2020
Q2 | $341K | Buy |
3,050
+1
| +0% | +$112 | 0.14% | 98 |
|
|
2020
Q1 | $236K | Hold |
3,049
| – | – | 0.18% | 71 |
|
|
2019
Q4 | $290K | Buy |
+3,049
| New | +$290K | 0.11% | 107 |
|